ATAD1 and malaria: Polymorphic antigens expressed in the blood stage of the parasite, such as the merozoite surface protein 1 (MSP1), MSP2, and glutamate-rich protein (GLURP), among others,7 have been studied in clinical trials for their potential as malaria vaccines, and several of them are widely used as molecular markers in the characterization of parasite populations and in the definition of treatment failures in drug trials.8